Connect with us

Health

Two vaccines elicit durable neutralizing antibody responses to SARS-CoV-2 in pre-clinical study – News-Medical.Net

A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian…

Published

on

Article feature image

A group of scientists led by researchers at the University of North Carolina at Chapel Hill, Weill Cornell Medicine and NewYork-Presbyterian reported that the Moderna mRNA vaccine and a protein-based vaccine candidate elicited durable neutralizing antibody…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending